Suzuki Shodai, Yamamoto Yoshiyuki, Kato Taigo, Hatano Koji, Matsui Takahiro, Hashimoto Kae, Miyamura Takako, Nagashima Yoji, Nonomura Norio, Kawashima Atsunari
Department of Urology Osaka University Graduate School of Medicine Suita Osaka Japan.
Department of Pathology Osaka University Graduate School of Medicine Suita Osaka Japan.
IJU Case Rep. 2024 Dec 26;8(2):109-113. doi: 10.1002/iju5.12820. eCollection 2025 Mar.
Hereditary leiomyomatosis and renal cell cancer is an autosomal dominant disorder caused by germline mutations in the gene and is associated with poor prognosis of aggressive renal cancer.
A 33-year-old man presented with asymptomatic gross hematuria and was diagnosed with a right renal tumor, cT3aN1M0. He underwent open radical nephrectomy, and pathological examination revealed papillary renal cell carcinoma. Despite aggressive treatment, the disease progressed rapidly, and discussions regarding genetic testing could not take place during his lifetime, although circulating-tumor DNA showed mutation of gene. After death, his wife requested postmortem genetic testing. Genetic analysis using DNA extracted from normal kidney tissues in surgical specimens (blood sample absence) confirmed the mutation, and hereditary leiomyomatosis and renal cell cancer was diagnosed posthumously.
This highlights the utility of postmortem genetic testing of surgical specimens to diagnose hereditary leiomyomatosis and renal cell cancer and provide genetic counseling to families, despite limitations during the patient's life.
遗传性平滑肌瘤病和肾细胞癌是一种常染色体显性疾病,由该基因的种系突变引起,与侵袭性肾癌的不良预后相关。
一名33岁男性因无症状肉眼血尿就诊,被诊断为右肾肿瘤,cT3aN1M0。他接受了开放性根治性肾切除术,病理检查显示为乳头状肾细胞癌。尽管进行了积极治疗,但疾病进展迅速,虽然循环肿瘤DNA显示该基因突变,但在其生前未能进行基因检测讨论。患者死后,其妻子要求进行尸检基因检测。使用手术标本中正常肾组织提取的DNA(无血样)进行基因分析,证实了该突变,死后诊断为遗传性平滑肌瘤病和肾细胞癌。
这突出了手术标本的尸检基因检测在诊断遗传性平滑肌瘤病和肾细胞癌以及为家庭提供遗传咨询方面的作用,尽管在患者生前存在局限性。